Insulin Attenuates Beta-Amyloid-Associated Insulin/Akt/EAAT Signaling Perturbations in Human Astrocytes.

Insulin Attenuates Beta-Amyloid-Associated Insulin/Akt/EAAT Signaling Perturbations in Human Astrocytes.
复制标题

DOI:
10.1007/s10571-015-0268-5
复制
发表时间:
2016-08
影响因子:
4
通讯作者:
Du Y
Du Y
中科院分区:
医学3区
文献类型:
--
作者:
Han X;Yang L;Du H;Sun Q;Wang X;Cong L;Liu X;Yin L;Li S;Du Y

文献摘要

参考文献

被引文献

相似文献

The excitatory amino acid transporters 1 and 2 (EAAT1 and EAAT2), mostly located on astrocytes, are the main mediators for glutamate clearance in humans. Malfunctions of these transporters may lead to excessive glutamate accumulation and subsequent excitotoxicity to neurons, which has been implicated in many kinds of neurodegenerative disorders including Alzheimer’s disease (AD). Yet, the specific mechanism of the glutamate system dysregulation remains vague. To explore whether the insulin/protein kinase B (Akt)/EAAT signaling in human astrocytes could be disturbed by beta-amyloid protein (Aβ) and be protected by insulin, we incubated HA-1800 cells with varying concentrations of Aβ1–42 oligomers and insulin. Then the alterations of several key substrates in this signal transduction pathway were determined. Our results showed that expressions of insulin receptor, phospho-insulin receptor, phospho-protein kinase B, phospho-mammalian target of rapamycin, and EAAT1 and EAAT2 were decreased by the Aβ1–42 oligomers in a dose-dependent manner (p < 0.05) and this trend could be recovered by insulin treatment (p < 0.05). However, the expressions of total Akt and mTOR were invariant (p > 0.05), and the mRNA levels of EAAT1 and EAAT2 were also unchanged (p > 0.05). Taken together, this study indicates that Aβ1–42 oligomers could cause disturbances in insulin/Akt/EAAT signaling in astrocytes, which might be responsible for AD onset and progression. Additionally, insulin can exert protective functions to the brain by modulating protein modifications or expressions.
DOI: 10.1042/an20130017
发表时间: 2013-10-07
期刊: ASN neuro
影响因子: 4.7
作者:
Kulijewicz-Nawrot M;Syková E;Chvátal A;Verkhratsky A;Rodríguez JJ
通讯作者: Rodríguez JJ
DOI: 10.1001/archneurol.2011.233
发表时间: 2012-01
影响因子: --
作者:
Craft, Suzanne;Baker, Laura D.;Montine, Thomas J.;Minoshima, Satoshi;Watson, G. Stennis;Claxton, Amy;Arbuckle, Matthew;Callaghan, Maureen;Tsai, Elaine;Plymate, Stephen R.;Green, Pattie S.;Leverenz, James;Cross, Donna;Gerton, Brooke
通讯作者: Gerton, Brooke
DOI: 10.1016/j.ceca.2011.11.008
发表时间: 2012-02-01
期刊: CELL CALCIUM
影响因子: 4
作者:
Ferreira, I. L.;Bajouco, L. M.;Rego, A. C.
通讯作者: Rego, A. C.
DOI: 10.2967/jnumed.110.087031
发表时间: 2012-01-01
影响因子: 9.3
作者:
Carter, Stephen F.;Scholl, Michael;Nordberg, Agneta
通讯作者: Nordberg, Agneta
DOI: 10.1016/j.euroneuro.2014.06.008
发表时间: 2014-12
影响因子: 5.6
作者:
de la Monte, Suzanne M.
通讯作者: de la Monte, Suzanne M.